Life Technologies Teams with Gen-Probe Life Sciences to Provide Elucigene QST*R Aneuploidy Kits

CARLSBAD, Calif. – March 20, 2010 – Life Technologies Corporation today announced a partnership with Gen-Probe Life Sciences Ltd., to commercialize Gen-Probe’s Elucigene QST*R Aneuploidy Kits under the Applied Biosystems brand in Eastern Europe, Asia, Africa, Australia, Latin America and Canada. The kits will not be available for sale in the U.S.

“Through our collaboration with Gen-Probe Life Sciences, we will be providing diagnostic labs with specialized kits for the rapid and unambiguous analysis of the most common viable human aneuploidies or chromosomal abnormalities, including Down syndrome,” said Andy Felton, Ph. D., Director, Genetic Systems Division at Life Technologies. “By working with Gen-Probe Life Sciences, we take another important step toward our continued commitment to deliver high value diagnostic assays for use in the clinic. This agreement exemplifies Life Technologies’ dedication to deliver easy to use, highly accurate applications on our CE sequencing systems.”

The kits are labeled for use in diagnostics and work in conjunction with the Applied Biosystems industry-leading line of capillary electrophoresis (CE) systems, including the new 3500 Series Genetic Analyzer. Initial sales of the Applied Biosystems branded kits are anticipated to begin mid-year 2010.

“Gen-Probe Life Sciences is pleased to collaborate with Life Technologies in a combined effort to contribute to advancing molecular medicine,” said Mike Webb, General Manager of Elucigene products for Gen-Probe Life Sciences. “This partnership will enable a wider global presence for our technology which we deeply believe helps improve prenatal care.”

“This joint relationship signifies a combined commitment in providing diagnostic tools for clinical applications,” said Scott Higgins, Business Manager for Gen-Probe Life Sciences. “Through its collaboration with Applied Biosystems, Gen-Probe Life Sciences will be able to provide Aneuploidy Detection Kits to a wider international clinical community.”

About Life Technologies (
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference, please visit us online at Follow Life Technologies on Twitter @LIFECorporation and on Facebook.

Life Technologies Contact
Patty Zamora